NCT04618718 - The PROTEMBO C Trial | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 31, 2020

Primary Completion Date

November 23, 2022

Study Completion Date

November 23, 2022

Conditions

Valvular Heart Disease

Interventions

DEVICE

cerebral embolic protection during TAVR

The ProtEmbo system is an adjunctive device placed in the central arterial system at the beginning of a TAVR procedure to deflect embolic particles during the procedure and removed following the completion of the procedure.

Trial Locations (8)

23538

Universitätsklinikum Schleswig-Holstein (UKSH), Lübeck

24105

Universitätsklinikum Schleswig-Holstein, Kiel

54292

Krankenhaus der Barmherzigen Brüder Trier, Trier

04289

Herzzentrum Leipzig-Universitätsklinik für Kardiologie-Helios, Leipzig

Unknown

Pauls Stradins Clinical University Hospital, Riga

Department of Interventional Cardiology Warsaw Institute of Cardiology, Warsaw

80-214

Uniwersyteckie Centrum Kliniczne, Gdansk

61-848

Szpital Kliniczny Przemienienia Panskiego Poznan University of Medical Sciences, Poznan